|
JPH0637520B2
(ja)
*
|
1985-07-03 |
1994-05-18 |
味の素株式会社 |
ポリペプチド
|
|
EP0272253A4
(en)
|
1986-03-07 |
1990-02-05 |
Massachusetts Inst Technology |
METHOD FOR IMPROVING GLYCOPROTE INSTABILITY.
|
|
US4973577A
(en)
|
1986-04-04 |
1990-11-27 |
The Salk Institute For Biological Studies |
FSH-releasing peptides
|
|
US5080891A
(en)
|
1987-08-03 |
1992-01-14 |
Ddi Pharmaceuticals, Inc. |
Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5096815A
(en)
|
1989-01-06 |
1992-03-17 |
Protein Engineering Corporation |
Generation and selection of novel dna-binding proteins and polypeptides
|
|
US5198346A
(en)
|
1989-01-06 |
1993-03-30 |
Protein Engineering Corp. |
Generation and selection of novel DNA-binding proteins and polypeptides
|
|
AU8761391A
(en)
|
1990-09-13 |
1992-04-15 |
Children's Hospital Medical Center Of Northern California |
Method for increasing red blood cell production by treatment with activin or activin-related peptides
|
|
US5118667A
(en)
|
1991-05-03 |
1992-06-02 |
Celtrix Pharmaceuticals, Inc. |
Bone growth factors and inhibitors of bone resorption for promoting bone formation
|
|
WO1992020793A1
(en)
|
1991-05-10 |
1992-11-26 |
The Salk Institute For Biological Studies |
CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-β SUPERFAMILY
|
|
US5885794A
(en)
|
1991-05-10 |
1999-03-23 |
The Salk Institute For Biological Studies |
Recombinant production of vertebrate activin receptor polypeptides and identification of receptor DNAs in the activin/TGF-β superfamily
|
|
US6162896A
(en)
|
1991-05-10 |
2000-12-19 |
The Salk Institute For Biological Studies |
Recombinant vertebrate activin receptors
|
|
US20050186593A1
(en)
|
1991-05-10 |
2005-08-25 |
The Salk Institute For Biological Studies |
Cloning and recombinant production of CRF receptor(s)
|
|
DK0592562T3
(da)
|
1991-06-25 |
1999-08-30 |
Genetics Inst |
BMP-9-præparater
|
|
US6287816B1
(en)
|
1991-06-25 |
2001-09-11 |
Genetics Institute, Inc. |
BMP-9 compositions
|
|
AU3968793A
(en)
*
|
1992-04-02 |
1993-11-08 |
United States Of America, As Represented By The Secretary Of Health And Human Services |
Use of restriction endonucleases against viruses, including HIV
|
|
US6692925B1
(en)
|
1992-11-17 |
2004-02-17 |
Ludwig Institute For Cancer Research |
Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use
|
|
JPH08505771A
(ja)
|
1993-01-12 |
1996-06-25 |
ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン |
増殖分化因子−３
|
|
US5637480A
(en)
|
1993-05-12 |
1997-06-10 |
Genetics Institute, Inc. |
DNA molecules encoding bone morphogenetic protein-10
|
|
CA2161807A1
(en)
|
1993-05-12 |
1994-11-24 |
Anthony J. Celeste |
Bmp-10 compositions
|
|
US5677196A
(en)
|
1993-05-18 |
1997-10-14 |
University Of Utah Research Foundation |
Apparatus and methods for multi-analyte homogeneous fluoro-immunoassays
|
|
US5831050A
(en)
*
|
1993-06-07 |
1998-11-03 |
Creative Biomolecules, Inc. |
Morphogen cell surface receptor
|
|
CA2174098C
(en)
|
1993-10-14 |
2011-01-25 |
Douglas A. Melton |
Method of inducing and maintaining neuronal cells
|
|
US5525490A
(en)
|
1994-03-29 |
1996-06-11 |
Onyx Pharmaceuticals, Inc. |
Reverse two-hybrid method
|
|
US5658876A
(en)
|
1994-04-28 |
1997-08-19 |
The General Hospital Corporation |
Activin antagonists as novel contraceptives
|
|
US5863738A
(en)
*
|
1994-04-29 |
1999-01-26 |
Creative Biomolecules, Inc. |
Methods of antagonizing OP-1 binding to a cell surface receptor utilizing ALK polypeptides
|
|
IL114397A0
(en)
*
|
1994-07-01 |
1995-10-31 |
Bioph Biotech Entw Pharm Gmbh |
Growth/differentiation factor of the TGF-beta-family
|
|
US5760010A
(en)
|
1995-01-01 |
1998-06-02 |
Klein; Ira |
Method of treating liver disorders with a macrolide antibiotic
|
|
IL117175A
(en)
*
|
1995-02-20 |
2005-11-20 |
Sankyo Co |
Osteoclastogenesis inhibitory factor protein
|
|
US5814565A
(en)
|
1995-02-23 |
1998-09-29 |
University Of Utah Research Foundation |
Integrated optic waveguide immunosensor
|
|
NZ502795A
(en)
|
1995-04-11 |
2001-09-28 |
Gen Hospital Corp |
Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems
|
|
US6132988A
(en)
*
|
1995-10-27 |
2000-10-17 |
Takeda Chemical Industries, Ltd. |
DNA encoding a neuronal cell-specific receptor protein
|
|
GB9526131D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Recombinant chimeric receptors
|
|
US20050244867A1
(en)
|
1996-03-26 |
2005-11-03 |
Human Genome Sciences, Inc. |
Growth factor HTTER36
|
|
US6004780A
(en)
|
1996-03-26 |
1999-12-21 |
Human Genome Sciences, Inc. |
Growth factor HTTER36
|
|
EP0939816A1
(en)
|
1996-10-25 |
1999-09-08 |
G.D. SEARLE & CO. |
Circularly permuted erythropoietin receptor agonists
|
|
US6605699B1
(en)
*
|
1997-01-21 |
2003-08-12 |
Human Genome Sciences, Inc. |
Galectin-11 polypeptides
|
|
US6034062A
(en)
|
1997-03-13 |
2000-03-07 |
Genetics Institute, Inc. |
Bone morphogenetic protein (BMP)-9 compositions and their uses
|
|
US6231880B1
(en)
|
1997-05-30 |
2001-05-15 |
Susan P. Perrine |
Compositions and administration of compositions for the treatment of blood disorders
|
|
AU745122B2
(en)
|
1997-07-30 |
2002-03-14 |
Emory University |
Novel bone mineralization proteins, DNA, vectors, expression systems
|
|
US6656475B1
(en)
*
|
1997-08-01 |
2003-12-02 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
|
|
US6696260B1
(en)
*
|
1997-08-01 |
2004-02-24 |
The Johns Hopkins University School Of Medicine |
Methods to identify growth differentiation factor (GDF) binding proteins
|
|
US6891082B2
(en)
*
|
1997-08-01 |
2005-05-10 |
The Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a truncated activintype II receptor
|
|
AU8666398A
(en)
|
1997-08-01 |
1999-02-22 |
Johns Hopkins University School Of Medicine, The |
Methods to identify growth differentiation factor (gdf) receptors
|
|
US6953662B2
(en)
*
|
1997-08-29 |
2005-10-11 |
Human Genome Sciences, Inc. |
Follistatin-3
|
|
US6372454B2
(en)
|
1997-08-29 |
2002-04-16 |
Human Genome Sciences, Inc. |
Nucleic acid molecules encoding Follistatin-3
|
|
BR9812846A
(pt)
|
1997-10-03 |
2000-08-08 |
Chugai Pharmaceutical Co Ltd |
Anticorpo humanizado natural
|
|
US6696411B1
(en)
|
1998-04-22 |
2004-02-24 |
Cornell Research Foundation, Inc. |
Canine erythropoietin gene and recombinant protein
|
|
CA2330939A1
(en)
|
1998-06-16 |
1999-12-23 |
Biogen, Inc. |
Variant type ii tgf-beta receptor fusion proteins and methods
|
|
AU765584B2
(en)
*
|
1998-09-17 |
2003-09-25 |
Eli Lilly And Company |
Protein formulations
|
|
EP1116792B1
(en)
|
1998-09-22 |
2007-01-24 |
Long Yu |
New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
|
|
US6472179B2
(en)
*
|
1998-09-25 |
2002-10-29 |
Regeneron Pharmaceuticals, Inc. |
Receptor based antagonists and methods of making and using
|
|
US6548634B1
(en)
|
1998-09-30 |
2003-04-15 |
Chiron Corporation |
Synthetic peptides having FGF receptor affinity
|
|
US6238860B1
(en)
|
1998-11-05 |
2001-05-29 |
Dyax Corp. |
Binding moieties for human parvovirus B19
|
|
US6777205B1
(en)
|
1998-11-06 |
2004-08-17 |
Sterrenbeld Biotechnologie North America, Inc. |
Host cells expressing recombinant human erythropoietin
|
|
EP2261335B1
(en)
*
|
1998-11-27 |
2017-06-14 |
UCB Pharma S.A. |
Compositions and methods for increasing bone mineralisation
|
|
US20040009535A1
(en)
*
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
|
NZ513642A
(en)
|
1999-01-21 |
2004-02-27 |
Metamorphix Inc |
Growth differentiation factor inhibitors and uses therefor
|
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
|
EP1174149A1
(en)
|
1999-04-19 |
2002-01-23 |
Kyowa Hakko Kogyo Co., Ltd. |
Proliferation inhibitor for androgen-independent tumor
|
|
US6468543B1
(en)
|
1999-05-03 |
2002-10-22 |
Zymogenetics, Inc. |
Methods for promoting growth of bone using ZVEGF4
|
|
EP1231943A1
(en)
|
1999-11-12 |
2002-08-21 |
Maxygen Holdings Ltd |
Interferon gamma conjugates
|
|
AU777166B2
(en)
|
1999-12-15 |
2004-10-07 |
Research Development Foundation |
Betaglycan as an inhibin receptor and uses thereof
|
|
US20030224501A1
(en)
|
2000-03-17 |
2003-12-04 |
Young Paul E. |
Bone morphogenic protein polynucleotides, polypeptides, and antibodies
|
|
JP4487376B2
(ja)
*
|
2000-03-31 |
2010-06-23 |
味の素株式会社 |
腎疾患治療剤
|
|
PL219131B1
(pl)
|
2000-05-15 |
2015-03-31 |
Hoffmann La Roche |
Ciekła kompozycja farmaceutyczna, sposób jej wytwarzania oraz jej zastosowanie
|
|
US6627424B1
(en)
|
2000-05-26 |
2003-09-30 |
Mj Bioworks, Inc. |
Nucleic acid modifying enzymes
|
|
WO2002008277A2
(en)
|
2000-07-19 |
2002-01-31 |
Eli Lilly And Company |
Nucleic acids, vectors, host cells, polypeptides, and uses thereof
|
|
US6632180B1
(en)
|
2000-09-07 |
2003-10-14 |
John H. Laragh |
Method for evaluating and treating hypertension
|
|
DE10045591A1
(de)
|
2000-09-15 |
2002-04-04 |
Klaus Pfizenmaier |
Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine)
|
|
AU2002213251B2
(en)
|
2000-10-16 |
2007-06-14 |
Bristol-Myers Squibb Company |
Protein scaffolds for antibody mimics and other binding proteins
|
|
US7087224B2
(en)
|
2000-10-31 |
2006-08-08 |
Amgen Inc. |
Method of treating anemia by administering IL-1ra
|
|
CA2429473C
(en)
|
2000-11-20 |
2011-02-15 |
The Board Of Trustees Of The University Of Illinois |
Membrane scaffold proteins
|
|
AU2002236558A1
(en)
|
2000-12-01 |
2002-06-11 |
Regents Of The University Of California |
Method and composition for modulating bone growth
|
|
US20030082233A1
(en)
|
2000-12-01 |
2003-05-01 |
Lyons Karen M. |
Method and composition for modulating bone growth
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
TW200526779A
(en)
*
|
2001-02-08 |
2005-08-16 |
Wyeth Corp |
Modified and stabilized GDF propeptides and uses thereof
|
|
US20040132971A1
(en)
*
|
2001-02-09 |
2004-07-08 |
Haaning Jesper Mortensen |
Rank ligand-binding polypeptides
|
|
US20040132675A1
(en)
|
2002-02-08 |
2004-07-08 |
Calvin Kuo |
Method for treating cancer and increasing hematocrit levels
|
|
US7294472B2
(en)
*
|
2001-03-14 |
2007-11-13 |
Caden Biosciences |
Method for identifying modulators of G protein coupled receptor signaling
|
|
EP1369130A1
(en)
|
2001-03-16 |
2003-12-10 |
Takeda Chemical Industries, Ltd. |
Process for producing sustained release preparation
|
|
PT1390535E
(pt)
|
2001-04-26 |
2010-10-04 |
Amgen Mountain View Inc |
Bibliotecas combinatórias de domínios monoméricos
|
|
JP2004535182A
(ja)
|
2001-05-24 |
2004-11-25 |
ザイモジェネティクス，インコーポレイティド |
Ｔａｃｉ−免疫グロブリン融合タンパク質
|
|
WO2002094864A2
(en)
|
2001-05-25 |
2002-11-28 |
Genset S.A. |
Human cdnas and proteins and uses thereof
|
|
AUPR638101A0
(en)
|
2001-07-13 |
2001-08-09 |
Bioa Pty Limited |
Composition and method for treatment of disease
|
|
US7396642B2
(en)
|
2001-07-17 |
2008-07-08 |
Teijin Limited |
Methods of screening for a compound that enhances thermogenesis
|
|
US6855344B2
(en)
*
|
2001-07-17 |
2005-02-15 |
Integrated Chinese Medicine Holdings, Ltd. |
Compositions and methods for prostate and kidney health and disorders, an herbal preparation
|
|
KR100453877B1
(ko)
|
2001-07-26 |
2004-10-20 |
메덱스젠 주식회사 |
연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
|
|
US7320789B2
(en)
|
2001-09-26 |
2008-01-22 |
Wyeth |
Antibody inhibitors of GDF-8 and uses thereof
|
|
US6784154B2
(en)
*
|
2001-11-01 |
2004-08-31 |
University Of Utah Research Foundation |
Method of use of erythropoietin to treat ischemic acute renal failure
|
|
JP2005524612A
(ja)
|
2001-12-06 |
2005-08-18 |
ファイブローゲン、インコーポレーテッド |
内因性エリスロポエチン（ｅｐｏ）を増加させる方法
|
|
US20030144203A1
(en)
|
2001-12-19 |
2003-07-31 |
Voyager Pharmaceutical Corporation |
Methods for slowing senescence and treating and preventing diseases associated with senescence
|
|
US20060234918A1
(en)
|
2001-12-19 |
2006-10-19 |
Voyager Pharmaceutical Corporation |
Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors
|
|
US6998118B2
(en)
|
2001-12-21 |
2006-02-14 |
The Salk Institute For Biological Studies |
Targeted retrograde gene delivery for neuronal protection
|
|
BR0307548A
(pt)
|
2002-02-11 |
2006-01-17 |
Genentech Inc |
Método de produção de uma variante de anticorpo, variante de anticorpo, composição, ácido nucléico isolado, vetor, célula hospedeira, processo para a produção de uma variante de anticorpo e método de determinação do coeficiente de associação de antìgeno de um anticorpo
|
|
JP4429729B2
(ja)
|
2002-02-21 |
2010-03-10 |
ワイス エルエルシー |
Ｇａｓｐ１；フォリスタチンドメイン含有タンパク質
|
|
US20030219846A1
(en)
|
2002-02-28 |
2003-11-27 |
Pfizer Inc. |
Assay for activity of the ActRIIB kinase
|
|
AU2003232485A1
(en)
*
|
2002-04-18 |
2003-10-27 |
Mtm Laboratories Ag |
Neopeptides and methods useful for detection and treatment of cancer
|
|
DE10234192B4
(de)
|
2002-07-26 |
2009-11-26 |
Epoplus Gmbh Co.Kg |
Verwendung von Erythropoetin
|
|
RU2005107330A
(ru)
|
2002-08-16 |
2005-10-10 |
Уайт (Us) |
Эстроген-чувствительный элемент вмр-2 и способы его применения
|
|
US7261893B2
(en)
*
|
2002-10-22 |
2007-08-28 |
Wyeth |
Neutralizing antibodies against GDF-8 and uses therefor
|
|
US20040223966A1
(en)
*
|
2002-10-25 |
2004-11-11 |
Wolfman Neil M. |
ActRIIB fusion polypeptides and uses therefor
|
|
AU2002953327A0
(en)
|
2002-12-12 |
2003-01-09 |
Monash University |
Methods of diagnosing prognosing and treating activin associated diseases and conditions
|
|
JP5390070B2
(ja)
|
2003-02-07 |
2014-01-15 |
プロメティック、バイオサイエンシーズ、インコーポレーテッド |
赤血球形成刺激薬としての中鎖脂肪酸、グリセリド、および類似体
|
|
US20040197828A1
(en)
|
2003-03-26 |
2004-10-07 |
Gaddy Dana P. |
Method for diagnosis and treatment of bone turnover
|
|
US20070184052A1
(en)
*
|
2003-05-09 |
2007-08-09 |
Lin Herbert Y |
Soluble tgf-b type III receptor fusion proteins
|
|
CN1829532A
(zh)
|
2003-06-02 |
2006-09-06 |
惠氏公司 |
肌肉抑制素（gdf8）抑制剂和皮质类固醇联合用于治疗神经肌肉紊乱的用途
|
|
AU2004262640B2
(en)
|
2003-06-16 |
2010-12-23 |
Ucb Manufacturing, Inc. |
Antibodies specific for sclerostin and methods for increasing bone mineralization
|
|
WO2005009460A2
(en)
|
2003-07-25 |
2005-02-03 |
Medexis, S.A. |
Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer
|
|
US8895540B2
(en)
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
|
EP1706428B1
(en)
*
|
2004-01-22 |
2009-09-23 |
MERCK PATENT GmbH |
Anti-cancer antibodies with reduced complement fixation
|
|
US20050197292A1
(en)
*
|
2004-01-30 |
2005-09-08 |
Glennda Smithson |
Compositions and methods for treating T-cell mediated pathological conditions
|
|
WO2005094871A2
(en)
*
|
2004-03-26 |
2005-10-13 |
Acceleron Pharma Inc. |
Bmp-3 propeptides and related methods
|
|
AU2005230854A1
(en)
|
2004-03-31 |
2005-10-20 |
Xencor, Inc |
BMP-7 variants with improved properties
|
|
WO2005113590A2
(en)
|
2004-05-12 |
2005-12-01 |
Acceleron Pharma Inc. |
Bmp10 propeptides and related methods
|
|
US7465706B2
(en)
|
2004-06-24 |
2008-12-16 |
Acceleron Pharma Inc. |
GDF3 propeptides and related methods
|
|
EP2314617B1
(en)
|
2004-07-23 |
2015-06-24 |
Acceleron Pharma Inc. |
ActRII receptor polypeptides
|
|
US8617815B2
(en)
|
2004-08-05 |
2013-12-31 |
The Regents Of The University Of California |
Molecules with effects on cellular development and function
|
|
CN101001642A
(zh)
|
2004-08-12 |
2007-07-18 |
惠氏公司 |
使用gdf－8抑制剂对糖尿病、肥胖症和心血管病的联合治疗
|
|
EP1804824B1
(en)
|
2004-09-29 |
2017-01-04 |
Icahn School of Medicine at Mount Sinai |
Fsh and fsh receptor modulator compositions and methods for inhibiting osteoclastic bone resorption and bone loss in osteoporosis
|
|
CA2587424A1
(en)
|
2004-11-16 |
2006-05-26 |
Avidia Research Institute |
Protein scaffolds and uses thereof
|
|
NL1027887C2
(nl)
|
2004-12-24 |
2006-06-27 |
Bosch Gmbh Robert |
Transmissie met gebombeerde poelieschijven en een drijfriem.
|
|
NZ538097A
(en)
|
2005-02-07 |
2006-07-28 |
Ovita Ltd |
Method and compositions for improving wound healing
|
|
ES2547866T3
(es)
|
2005-02-16 |
2015-10-09 |
The General Hospital Corporation |
Uso de proteínas de fusión de hemojuvelina para regular el metabolismo del hierro mediado por hepcidina
|
|
PE20061395A1
(es)
|
2005-04-25 |
2007-01-15 |
Amgen Fremont Inc |
Anticuerpos contra miostatina
|
|
KR20080003929A
(ko)
|
2005-04-26 |
2008-01-08 |
아지노모토 가부시키가이샤 |
골수 적혈구 전구 세포 분화 촉진제
|
|
JP2007099764A
(ja)
|
2005-09-09 |
2007-04-19 |
Ajinomoto Co Inc |
血糖低下剤
|
|
PL1931697T3
(pl)
|
2005-09-28 |
2011-03-31 |
Zymogenetics Inc |
Antagoniści interleukiny IL-17A i IL-17F oraz sposoby ich zastosowania
|
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
|
PT1973559E
(pt)
|
2005-11-23 |
2013-02-19 |
Acceleron Pharma Inc |
Antagonistas de activina-actriia e utilizações para promover o crescimento ósseo
|
|
US8128933B2
(en)
|
2005-11-23 |
2012-03-06 |
Acceleron Pharma, Inc. |
Method of promoting bone growth by an anti-activin B antibody
|
|
AU2006321906C1
(en)
|
2005-12-06 |
2014-01-16 |
Amgen Inc. |
Uses of myostatin antagonists
|
|
EP1966183A4
(en)
|
2005-12-20 |
2010-12-29 |
Merck Frosst Canada Ltd |
HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A-DELTA-9-DESATURASE
|
|
WO2007075702A2
(en)
|
2005-12-21 |
2007-07-05 |
Schering Corporation |
Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and h3 receptor antagonist/inverse agonist
|
|
EP1973909A2
(en)
|
2005-12-22 |
2008-10-01 |
Biogen Idec MA Inc. |
Transforming growth factor modulators
|
|
US7361510B2
(en)
*
|
2006-01-20 |
2008-04-22 |
Beckman Coulter, Inc. |
Methods of detection of iron deficiency
|
|
US7820721B2
(en)
|
2006-01-25 |
2010-10-26 |
Wellstat Therapeutics Corporation |
Compounds for the treatment of metabolic disorders
|
|
CA2642662A1
(en)
|
2006-02-28 |
2007-09-07 |
Wellstat Therapeutics Corporation |
Compounds for the treatment of metabolic disorders
|
|
AU2007238705A1
(en)
|
2006-04-14 |
2007-10-25 |
Amgen Inc. |
Agonist erythropoietin receptor antibodies
|
|
WO2007123391A1
(en)
|
2006-04-20 |
2007-11-01 |
Academisch Ziekenhuis Leiden |
Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly expressed gene.
|
|
WO2007133653A2
(en)
|
2006-05-09 |
2007-11-22 |
Hemaquest Pharmaceuticals, Inc. |
Methods for treating blood disorders
|
|
TW200803123A
(en)
*
|
2006-06-02 |
2008-01-01 |
Delta Electronics Inc |
Power converter and magnetic structure thereof
|
|
CN101522021B
(zh)
|
2006-07-21 |
2014-07-30 |
莱因实验室 |
醋酸钙的液体组合物
|
|
GB0615129D0
(en)
|
2006-07-29 |
2006-09-06 |
Univ Cardiff |
Anti-cancer activity of BMP-9 and BMP-10 and their use in cancer therapies
|
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
|
US7547781B2
(en)
*
|
2006-09-11 |
2009-06-16 |
Curis, Inc. |
Quinazoline based EGFR inhibitors containing a zinc binding moiety
|
|
WO2008060139A1
(en)
|
2006-11-17 |
2008-05-22 |
Erasmus University Medical Center Rotterdam |
Methods for controlling mineralization of extracellular matrix, therapeutic methods based thereon and medicaments for use therein
|
|
WO2008073292A2
(en)
|
2006-12-08 |
2008-06-19 |
Caritas St. Elizabeth's Medical Center Of Boston, Inc. |
Method for protecting renal tubular epithelial cells from radiocontrast nephro parhy (rcn)
|
|
JP5632582B2
(ja)
|
2006-12-14 |
2014-11-26 |
中外製薬株式会社 |
抗Ｃｌａｕｄｉｎ３モノクローナル抗体およびそれを用いる癌の治療および診断
|
|
US8895016B2
(en)
|
2006-12-18 |
2014-11-25 |
Acceleron Pharma, Inc. |
Antagonists of activin-actriia and uses for increasing red blood cell levels
|
|
EA202091230A3
(ru)
*
|
2006-12-18 |
2021-01-29 |
Акселерон Фарма Инк. |
Антагонисты активин-actrii и их применения для повышения уровней эритроцитов
|
|
US20100028332A1
(en)
|
2006-12-18 |
2010-02-04 |
Acceleron Pharma Inc. |
Antagonists of actriib and uses for increasing red blood cell levels
|
|
CN107050424A
(zh)
|
2007-02-01 |
2017-08-18 |
阿塞勒隆制药公司 |
活化素‑actriia拮抗剂及在治疗或预防乳腺癌中的用途
|
|
TW201907946A
(zh)
|
2007-02-02 |
2019-03-01 |
美商艾瑟勒朗法瑪公司 |
衍生自ＡｃｔＲＩＩＢ的變體與其用途
|
|
TWI459963B
(zh)
*
|
2007-02-09 |
2014-11-11 |
Acceleron Pharma Inc |
包含ActRIIa-Fc融合蛋白的醫藥組合物；ActRIIa-Fc融合蛋白於治療或預防與癌症相關的骨質流失之用途；ActRIIa-Fc融合蛋白於治療或預防多發性骨髓瘤之用途
|
|
WO2013106175A1
(en)
|
2011-12-19 |
2013-07-18 |
Amgen Inc. |
Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
|
|
US8501678B2
(en)
|
2007-03-06 |
2013-08-06 |
Atara Biotherapeutics, Inc. |
Variant activin receptor polypeptides and uses thereof
|
|
TWI454479B
(zh)
|
2007-03-06 |
2014-10-01 |
Amgen Inc |
變異之活動素受體多肽及其用途
|
|
JP2010529041A
(ja)
|
2007-06-01 |
2010-08-26 |
ワイス・エルエルシー |
Ｂｍｐ−１０活性を調整する方法および組成物
|
|
WO2009009059A1
(en)
|
2007-07-09 |
2009-01-15 |
Biogen Idec Ma Inc. |
Spiro compounds as antagonists of tgf-beta
|
|
US20090025308A1
(en)
*
|
2007-07-26 |
2009-01-29 |
Deans Brian W |
Seismic support and reinforcement systems
|
|
RS55735B1
(sr)
|
2007-08-03 |
2017-07-31 |
Summit (Oxford) Ltd |
Kombinacije lekova za lečenje dišenove mišićne distrofije
|
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
GB0715938D0
(en)
|
2007-08-15 |
2007-09-26 |
Vastox Plc |
Method of treatment of duchenne muscular dystrophy
|
|
WO2009025651A1
(en)
|
2007-08-17 |
2009-02-26 |
University Of Maine System Board Of Trustees |
Biologically active peptide and method of using the same
|
|
WO2009035629A1
(en)
|
2007-09-13 |
2009-03-19 |
Ludwig Institute Of Cancer Research |
Method for modifying cellular immune response by modulating activin activity
|
|
WO2009038745A1
(en)
|
2007-09-18 |
2009-03-26 |
Acceleron Pharma Inc. |
Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion
|
|
PE20091163A1
(es)
|
2007-11-01 |
2009-08-09 |
Wyeth Corp |
Anticuerpos para gdf8
|
|
BRPI0820387A2
(pt)
|
2007-11-21 |
2015-05-26 |
Amgen Inc |
Agentes de ligação de wise e epítopos
|
|
US8507501B2
(en)
|
2008-03-13 |
2013-08-13 |
The Brigham And Women's Hospital, Inc. |
Inhibitors of the BMP signaling pathway
|
|
WO2009137075A1
(en)
*
|
2008-05-06 |
2009-11-12 |
Acceleron Pharma Inc. |
Anti-activin antibodies and uses for promoting bone growth
|
|
US20110104133A1
(en)
|
2008-05-06 |
2011-05-05 |
Joslin Diabetes Center, Inc. |
Methods and compositions for inducing brown adipogenesis
|
|
EP3363453A1
(en)
|
2008-06-26 |
2018-08-22 |
Acceleron Pharma Inc. |
Soluble actriia as activin-actriia antagonist for use in treating anemia or bone-related disorders
|
|
JP5773868B2
(ja)
|
2008-06-26 |
2015-09-02 |
アクセルロン ファーマ， インコーポレイテッド |
アクチビン−ＡｃｔＲＩＩａのアンタゴニストおよび赤血球レベルを高めるためのその使用
|
|
US8216997B2
(en)
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
|
ES2949049T3
(es)
|
2008-08-14 |
2023-09-25 |
Acceleron Pharma Inc |
Trampas de GDF
|
|
WO2010059861A1
(en)
|
2008-11-20 |
2010-05-27 |
University Of Southern California |
Compositions and methods to modulate hair growth
|
|
CN104371024A
(zh)
|
2008-11-26 |
2015-02-25 |
安姆根有限公司 |
激活素iib受体多肽的变异体及其用途
|
|
WO2010083034A1
(en)
|
2009-01-13 |
2010-07-22 |
Acceleron Pharma Inc. |
Methods for increasing adiponectin
|
|
US8110355B2
(en)
|
2009-02-20 |
2012-02-07 |
GenRemedy, LLC |
Methods for identifying agents that inhibit cell migration, promote cell adhesion and prevent metastasis
|
|
ES2655877T3
(es)
|
2009-04-27 |
2018-02-22 |
Novartis Ag |
Composiciones y métodos para aumentar el crecimiento muscular
|
|
AU2010258931B2
(en)
|
2009-06-08 |
2015-04-23 |
Acceleron Pharma Inc. |
Methods for increasing thermogenic adipocytes
|
|
CN102656187A
(zh)
|
2009-06-12 |
2012-09-05 |
阿塞勒隆制药公司 |
截短的actriib-fc融合蛋白
|
|
AU2010282361B2
(en)
|
2009-08-13 |
2015-03-19 |
Acceleron Pharma Inc. |
Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
|
|
AU2010292203A1
(en)
|
2009-09-09 |
2012-04-12 |
Acceleron Pharma Inc. |
ActRIIb antagonists and dosing and uses thereof
|
|
WO2011056896A1
(en)
|
2009-11-03 |
2011-05-12 |
Acceleron Pharma Inc. |
Methods for treating fatty liver disease
|
|
WO2011063018A1
(en)
|
2009-11-17 |
2011-05-26 |
Acceleron Pharma Inc. |
Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
|
|
WO2012027065A2
(en)
|
2010-08-27 |
2012-03-01 |
Celgene Corporation |
Combination therapy for treatment of disease
|
|
US8580922B2
(en)
|
2011-03-04 |
2013-11-12 |
Shire Human Genetic Therapies, Inc. |
Peptide linkers for polypeptide compositions and methods for using same
|
|
SI2726099T1
(sl)
|
2011-07-01 |
2018-11-30 |
Novartis Ag |
Postopek za zdravljenje metaboličnih motenj
|
|
EA202090053A3
(ru)
|
2011-10-17 |
2020-06-30 |
Акселерон Фарма, Инк. |
Способы и композиции для лечения неэффективного эритропоэза
|
|
US8765385B2
(en)
|
2011-10-27 |
2014-07-01 |
Ravindra Kumar |
Method of detection of neutralizing anti-actriib antibodies
|
|
WO2013063536A1
(en)
|
2011-10-27 |
2013-05-02 |
Acceleron Pharma, Inc. |
Actriib binding agents and uses thereof
|
|
WO2013059876A1
(en)
|
2011-10-28 |
2013-05-02 |
Paranta Biosciences Limited |
A method of treating mucus hypersecretion
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
EP2861620A2
(en)
|
2012-06-14 |
2015-04-22 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Use of blocking agents of bone morphogenie protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases
|
|
CN104411720B
(zh)
|
2012-07-02 |
2018-05-11 |
协和发酵麒麟株式会社 |
以抗bmp9抗体作为有效成分的、对肾性贫血、癌性贫血等贫血的治疗剂
|
|
CA2889286A1
(en)
|
2012-10-24 |
2014-05-01 |
Celgene Corporation |
Methods for treating anemia
|
|
IL290653B1
(en)
|
2012-10-24 |
2025-01-01 |
Celgene Corp |
Biomarker for use in the treatment of anemia
|
|
WO2014064292A1
(en)
|
2012-10-26 |
2014-05-01 |
Universite Pierre Et Marie Curie (Paris 6) |
A method for preventing or treating atrial fibrillation
|
|
EP3308796B1
(en)
|
2012-11-02 |
2021-07-14 |
Celgene Corporation |
Activin-actrii antagonists and uses for treating bone and other disorders
|
|
MX2020005126A
(es)
|
2012-11-08 |
2022-01-27 |
Clearside Biomedical Inc |
Metodos y dispositivos para el tratamiento de trastornos oculares en sujetos humanos.
|
|
US20150328249A1
(en)
|
2012-12-11 |
2015-11-19 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Modulation of myofiber repair by anti-myostatin strategies and/or ppar gamma ligands, alone or in combination with stem cells, for the therapy of critical limb ischemia and other ischemic processes affecting the skeletal muscle
|
|
US20140220033A1
(en)
|
2013-02-01 |
2014-08-07 |
Santa Maria Biotherapeutics, Inc. |
Administration of an Anti-Activin-A Compound to a Subject
|
|
WO2014152940A1
(en)
|
2013-03-14 |
2014-09-25 |
Shire Human Genetic Therapies, Inc. |
Mrna therapeutic compositions and use to treat diseases and disorders
|
|
TW201920262A
(zh)
|
2013-07-30 |
2019-06-01 |
美商再生元醫藥公司 |
抗活化素ａ之抗體及其用途
|
|
CN105960414A
(zh)
|
2013-08-14 |
2016-09-21 |
诺华股份有限公司 |
治疗散发性包涵体肌炎的方法
|
|
CA2932463A1
(en)
|
2013-12-16 |
2015-06-25 |
Paranta Biosciences Limited |
Method of diagnosis and treatment
|
|
US20160333418A1
(en)
|
2014-01-14 |
2016-11-17 |
Santa Maria Biotherapeutics, Inc. |
Activin Inhibitor Response Prediction and Uses for Treatment
|
|
JP2017510622A
(ja)
|
2014-01-27 |
2017-04-13 |
ノバルティス アーゲー |
筋萎縮を予測するバイオマーカー、方法および使用
|
|
WO2015152183A1
(ja)
|
2014-03-31 |
2015-10-08 |
大日本住友製薬株式会社 |
進行性骨化性線維異形成症の予防剤及び治療剤
|
|
MX2016013635A
(es)
|
2014-04-18 |
2017-02-02 |
Acceleron Pharma Inc |
Métodos para aumentar los niveles de eritrocitos y tratar de la enfermedad de células falciformes.
|
|
TW201622746A
(zh)
|
2014-04-24 |
2016-07-01 |
諾華公司 |
改善或加速髖部骨折術後身體復原之方法
|
|
CN113583104A
(zh)
|
2014-06-04 |
2021-11-02 |
阿塞勒隆制药公司 |
促滤泡素抑制素多肽、其组合物及其使用方法
|
|
PE20170471A1
(es)
|
2014-06-13 |
2017-05-14 |
Santa Maria Biotherapeutics Inc |
Polipeptidos receptores formulados y metodos relacionados
|
|
TWI814187B
(zh)
|
2015-05-13 |
2023-09-01 |
美商西建公司 |
使用ACTRII配位體捕捉以治療β-地中海型貧血
|